WatchGov

119th Congress

H.R. 1414

Cameron’s Law

  1. Introduced
  2. In committee
  3. Passed House
  4. Passed Senate
  5. To President
  6. Became law
Sponsor
Josh Gottheimer(D-NJ)
Introduced
Feb 18, 2025
Policy area
Taxation
Committees
House Committee on Ways and Means
Official text
Introduced in House · Congress.gov page

Cosponsors (19)

Original cosponsors (3)

Added later (16)

Summary

Summary by the Congressional Research Service· describes the “Introduced in House” version

Cameron's Law This bill increases the orphan drug tax credit to 50% (from 25%) of qualified clinical testing expenses paid or incurred in the development of drugs to treat certain rare diseases or conditions. As background, the Tax Cuts and Jobs Act reduced the orphan drug tax credit (for tax years after 2017) to 25% of qualified clinical testing expenses (e.g., wages, supplies, and certain contract expenses) paid or incurred in the development of drugs to treat certain rare diseases or conditions. For 2017 and prior tax years, the orphan tax credit was 50% of such expenses paid or incurred.

Roll-call votes

No recorded votes on this bill.

Actions